Emergent Biosolutions Market Cap 2010-2023 | EBS

Emergent Biosolutions market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Emergent Biosolutions market cap as of June 06, 2023 is $0.4B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.404B $1.121B
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company offering specialized products to health care providers and governments to combat emerging public health threats. It also supplies vaccines to domestic and international non-government organizations and governments in/ outside of the U.S. BioThrax is the company's key Biodefense product, used for anthrax disease. The U.S. government is the primary purchaser of the company's Biodefense products. It supplies adjuvanted anthrax vaccine candidate, AV7909, to the U.S. government. It supplies smallpox vaccine ACAM2000, botulism therapeutic BAT, anthrax therapeutics 'raxibacumab & Anthrasil' and 3 other products to governments of different countries. It also retails 3 products Narcan nasal spray, Vaxchora and Vivoti. It provides contract development and manufacturing services to multiple pharma and biotech companies. The company has added key products Narcan nasal spray, ACAM2000, raxibacumab, Vaxchora and Vivoti through several acquisitions.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.563B 8.41
GSK (GSK) United Kingdom $70.884B 9.89
Bio-Rad Laboratories (BIO.B) United States $10.988B 29.38
QIAGEN (QGEN) Netherlands $10.436B 22.03
Ginkgo Bioworks Holdings (DNA) United States $3.816B 0.00
Biohaven (BHVN) United States $1.544B 0.00
Arcus Biosciences (RCUS) United States $1.475B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.196B 0.00
Enzo Biochem (ENZ) United States $0.110B 0.00
SQZ Biotechnologies (SQZ) United States $0.016B 0.00